Corbus Pharmaceuticals Holdings, Inc.

By person

22 insiders · 140 transactions

1.9×

Yuval Cohen holds only 1.9 times base salary in stock. $1.23M of shares against $646.57K in salary for 2025.

Salary from the company's own proxy. The shares are what Yuval Cohen last reported holding, valued at $7.84, the price Common Stock, par value $0.0001 per share was last bought or sold at on the open market here, on 14 Sep 2026.

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Cormorant Asset Management, LP entity

10% owner

$53.69M (31)

$344.01K (1)

+$53.35M

2,344,971

12.12%

$18.39M

+430.1%

Cohen Yuval

Chief Executive Officer

$122.23K (15)

$3.76M (13) scheduled

−$3.64M

157,316

0.8134%

$1.23M

—

Moran Sean F.

Chief Financial Officer

$144.20K (12)

$1.54M (11) scheduled

−$1.40M

84,694

0.4379%

$664.13K

—

Hochman David P

Director

$269.18K (7)

—

+$269.18K

814,400

4.21%

$6.39M

+5.9%

White Barbara

Chief Medical Officer

$254.36K (12)

—

+$254.36K

206,217

1.07%

$1.62M

+28.0%

Saxena Nishant C

Chief Business Officer

$126.25K (3)

—

+$126.25K

77,900

0.4028%

$610.85K

+2,126%

Smethurst Dominic

Chief Medical Officer

—

$120.51K (3)

−$120.51K

89,790

0.4642%

$704.09K

—

Discordia Robert Paul

Chief Operating Officer

$109.51K (3)

—

+$109.51K

35,490

0.1835%

$278.29K

+134.3%

Panayiotopoulos Paris

Director

$100.39K (1)

—

+$100.39K

14,285

0.0739%

$112.02K

—

Millian Craig Stuart

Chief Operating Officer

$76.55K (8)

—

+$76.55K

27,000

0.1396%

$211.72K

—

Jenkins John Kenneth

Director

$6.98K (1)

$58.45K (2) scheduled

−$51.47K

3,833

0.0198%

$30.06K

—

Altmeyer Anne

Director

—

$50.91K (3) scheduled

−$50.91K

7,579

0.0392%

$59.43K

—

CATLIN AVERY W

Director

$45.84K (2)

—

+$45.84K

4,350

0.0225%

$34.11K

—

Hodgson Ian

Chief Operating Officer

—

$25.79K (2)

−$25.79K

51,080

0.2641%

$400.54K

+96.6%

Kung Winston

Director

—

$16.03K (1) scheduled

−$16.03K

12,140

0.0628%

$95.20K

—

Ben Yong

Director

—

$15.68K (1) scheduled

−$15.68K

9,383

0.0485%

$73.58K

—

HOLMER ALAN F

Director

$10.61K (2)

—

+$10.61K

10,629

0.0550%

$83.35K

—

Tepper Mark

President and CSO

—

2,110,400

10.91%

$16.55M

+0.5%

Nicacio Leonardo Viana

Chief Medical Officer

—

58,333

0.3016%

$457.42K

—

Jacques Rachelle Suzanne

Director

—

11,383

0.0589%

$89.26K

—

Pfeiffenberger Brent

Director

—

7,500

0.0388%

$58.81K

—

Salzmann Peter

Director

—

2,783

0.0144%

$21.82K

—

Individual transactions

Insider

Date

Role

Action

Price

Amount

HOLMER ALAN F

14 Jun 2024

Director

Exercised, kept

1,667

$30.00

$50.01K

Moran Sean F.

10 Apr 2024

Chief Financial Officer

Exercised, kept

1,787

$30.00

$53.61K

Cohen Yuval

26 Jan 2024

Chief Executive Officer

Exercised, kept

7,179

$4.97

$35.68K

HOLMER ALAN F

26 Jan 2024

Director

Exercised, kept

629

$4.97

$3.13K

Tepper Mark

14 Nov 2018

President and CSO

Exercised, kept

10,000

$1.00

$10.00K

Cohen Yuval

16 Mar 2017

Chief Executive Officer

Exercised, kept

20,000

$1.00

$20.00K

Show all 140 transactions →

Corbus Pharmaceuticals Holdings, Inc.

By person

Individual transactions

What was left out